» Articles » PMID: 29883396

No Reported Renal Stones with Intravenous Vitamin C Administration: A Prospective Case Series Study

Overview
Date 2018 Jun 9
PMID 29883396
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

A few cases associating high dose intravenous vitamin C (IVC) administration with renal stone formation have been reported in the literature, however, no long-term studies investigating IVC administration and reported renal stones have been carried out. Our aim was to measure the frequency of reported renal stones in patients receiving IVC therapy. We carried out a prospective case series study of 157 adult patients who commenced IVC therapy at Integrated Health Options clinic between 1 September 2011 and 31 August 2012, with follow-up for 12 months. Inquiries into the occurrence of renal stones were conducted at enrolment, 6 and 12 months, and renal function blood tests were conducted at enrolment, 4 weeks and every 12 weeks thereafter in a subgroup of patients. No renal stones were reported by any patients in the study, despite 8% of the patients having a history of renal stones. In addition, the majority of patients investigated had stable renal function during the study period as evidenced by little change in serum creatinine levels and estimated glomerular filtration rate (eGFR) following IVC. In conclusion, IVC therapy was not associated with patient-reported renal stones. Although not the primary focus of this study, it was also observed that there was no significant change in mean serum creatinine or eGFR for those who had follow-up renal function blood tests.

Citing Articles

The evidence to date: implications of l-ascorbic acid in the pathophysiology of aging.

Sato A, Kondo Y, Ishigami A J Physiol Sci. 2024; 74(1):29.

PMID: 38730366 PMC: 11088021. DOI: 10.1186/s12576-024-00922-7.


Vitamins as regulators of calcium-containing kidney stones - new perspectives on the role of the gut microbiome.

Chmiel J, Stuivenberg G, Al K, Akouris P, Razvi H, Burton J Nat Rev Urol. 2023; 20(10):615-637.

PMID: 37161031 PMC: 10169205. DOI: 10.1038/s41585-023-00768-5.


High-dose vitamin C on sepsis: Protocol of a prospective, multi-centered, double-blinded, randomized, and placebo-controlled superiority study.

Zhao B, Li M, Sun W, Li J, Liu L, Wang Y Front Med (Lausanne). 2022; 9:950246.

PMID: 36186784 PMC: 9520308. DOI: 10.3389/fmed.2022.950246.


Reduced Plasma Ascorbate and Increased Proportion of Dehydroascorbic Acid Levels in Patients Undergoing Hemodialysis.

Doshida Y, Itabashi M, Takei T, Takino Y, Sato A, Yumura W Life (Basel). 2021; 11(10).

PMID: 34685394 PMC: 8538838. DOI: 10.3390/life11101023.


Any Role of High-Dose Vitamin C for Septic Shock in 2021?.

Agarwal A, Hager D, Sevransky J Semin Respir Crit Care Med. 2021; 42(5):672-682.

PMID: 34544184 PMC: 8663751. DOI: 10.1055/s-0041-1733986.


References
1.
Ferraro P, Curhan G, Gambaro G, Taylor E . Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones. Am J Kidney Dis. 2015; 67(3):400-7. PMC: 4769668. DOI: 10.1053/j.ajkd.2015.09.005. View

2.
Marik P, Khangoora V, Rivera R, Hooper M, Catravas J . Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. Chest. 2016; 151(6):1229-1238. DOI: 10.1016/j.chest.2016.11.036. View

3.
Thomas L, Elinder C, Tiselius H, Wolk A, Akesson A . Ascorbic acid supplements and kidney stone incidence among men: a prospective study. JAMA Intern Med. 2013; 173(5):386-8. DOI: 10.1001/jamainternmed.2013.2296. View

4.
McHugh G, Graber M, Freebairn R . Fatal vitamin C-associated acute renal failure. Anaesth Intensive Care. 2008; 36(4):585-8. DOI: 10.1177/0310057X0803600413. View

5.
Dennis J, Witting P . Protective Role for Antioxidants in Acute Kidney Disease. Nutrients. 2017; 9(7). PMC: 5537833. DOI: 10.3390/nu9070718. View